ALK protein expression in pulmonary adenocarcinoma of Tunisian patients
Background. It is now necessary to determine ALK status in order to use targeted therapy. Aim: herein, we assess immunohistochemical profile of ALK protein in a series of Tunisian patients with pulmonary adenocarcinoma. Materials and Methods. ALK protein expression was studied applying the D5F3 anti...
Saved in:
Published in: | Journal of immunoassay & immunochemistry Vol. 38; no. 4; pp. 411 - 419 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Taylor & Francis
04-07-2017
Marcel Dekker, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background. It is now necessary to determine ALK status in order to use targeted therapy. Aim: herein, we assess immunohistochemical profile of ALK protein in a series of Tunisian patients with pulmonary adenocarcinoma.
Materials and Methods. ALK protein expression was studied applying the D5F3 antibody with a fully automated Ventana CDx technique on a series of 19 patients.
Results. Positive ALK expression was found in one case (5.2%) corresponding to a papillary adenocarcinoma which showed a strong granular and homogenous cytoplasmic staining. The patient was a 30-years-old woman.
Conclusion. The frequency of positive ALK expression based on immunohistochemistry in our series was similar to that reported in the world literature. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1532-1819 1532-4230 |
DOI: | 10.1080/15321819.2017.1319860 |